Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, I was deep into this big plan 20 years ago. Hold gold in Perth if you want out of the USA.
CYDY will take off but not on the BS timelines that NP puts out. I’m patient but I wish I had more than a measly 10k shares. If this stays around $3-$4 for another year I’ll be happy.
Dilution is hard to swallow at this level... lots of new bag holders created recently.
That’s likely true ... the FDA isn’t moving fast on anything and it looks like the USA is planning for another shutdown until early 2021.
Slower than molasses in January....
That hits the Naz in the nuts. Oh well... didn’t sound serious anyway. NP pumps.
These guys have to get serious...
NP gonna toss out a PR tomorrow to keep the SP above $4?
Gotta be a good one... otherwise the shorts will feast.
I would to IF it wasn’t under A DTC chill and in a graveyard.
Hopefully he knows what he’s talking about and not just teasing to save his ass.
He already has the therapeutic... what are they waiting for?
Hire a lobbyist, have Fauci out to the boat for drinks etc.
Media is just a tool of the rich to push the herd their direction.
If true, It seems as though NP takes his guidance from a select group of shareholders. Which can be good but also scary that he doesn’t know the basics himself.
I agree but I’m always hesitant due to possible FDA news. However at this point it seems CYDY can’t properly navigate the FDA waters.
If NP truly thinks he’s going to uplist he’ll need to have some credible FDA events in next day or so otherwise his Naz uplisting is in danger.
Agreed, HGEN just screwed the pooch on the uplist... we’ll see if they close above $3 today.
Why not expand the S2C P3 to countries outside the USA? HGEN expanded theirs to Brazil.
Another path to film enrollment.
Read the news NP... come on man.
This going subpenny? Good job Chas... WTF are you doing sir? This guy is a space cadet for sure. Come on man...
World better start approving ANY mab going into fall/winter. When the herd population starts losing Vitamin D due to less sun the symptoms and death rate will increase.... that’s the 2nd wave!
Clock is ticking... oh and it’s an election year... great...
Same criminals up and down
He’s kinda juvenile and insecure... needs help for sure. Or get out of the way.
I’m betting the BPngun club cringed when They have to deal with him.
Exactly, and I bet he was disappointed the SP didn’t jump a $1 afterward.
The drug working is priced in already. Many both short and long know this.. I don’t know why NP doesn’t.
The CC was comical, NP pit that on to address the concern (share price) that investors didn’t understand the M2M results. Lmao.
We ALREADY know the drug works! We are waiting on the EUA or ANY FDA response that is positive that can lead toward revenues.
Where’s the type A meeting?
Any chance BP people outside the BOD are trying to convince them they’ll lose their equity if they don’t fix NP?
Those guys hold a lot shares, is their loyalty to NP worth $millions?
I figure NP has this month to make good.
Well said... the fact that the drug works is priced in already. I think NP has overachieved. Can leronlimab overcome the management?
The BP gun club doesn’t take kindly to brazen outsiders.
I can hear it now... do we have to deal with this pompous ass? Lol.
That’s a shame. Opportunity will pass before they realize they’ve missed it.
Dr. Yo pumped Aviptadil today, Dr. Drew retweeted.
Amazing how leronlimab gets ignored.
Nader pinches a nickel hard.... I doubt he’ll be wise enough to pay for that service. Although he pays himself well...
It’s time to admit he needs professional help. He did his job to this point... let’s clean this penny up.
It’ll be delayed due to the hurricane
Agreed... my sarcasm is subtle.
NP has to be removed as CEO... need BPharm leadership.
I’m waiting for the new BOD members to start bailing now. They’ll get tired of NP not listening and pumping BS.
Did the news crew land yet at the furniture store? Damn Massachusetts hurricanes...
Hype and they missed the boat. Vaccines closer everyday and Vystar has little to sell.
Back to reality... somehow Long Longs knew a 100million market cap wouldn’t hold up. Lol.
That’s what I thought.. again... watch that close... CC pump today and no PR... looks like another drop and the Naz uplist gets reset.
Best thing the board can do is shelve NP on the call. Get him off the radar.
Yeah, cydy is giving him the attention he craves. NP is resurrecting AFs career by even acknowledging him or short attacks, that’s pretty dumb.
Well it’s is true that not holding $4 eliminates options.
Better hold $3 then....
Wouldn’t surprise me... balance sheet shows they need it
Yep, they suck at this. Well done!
Careful now... fall below $4 and Nasdaq uplisting is jeopardized.
Starting to unravel a bit.
That being said BPattersin is one cool cucumber... he’s like “Hey, chill out, the paper will get published, the drug works incredibly well, this takes time”.
I have no issue pinning it on cydy management. They are rookies at this game and it shows.
BOD needs to sack up and hire a CEO, move NP to BOD.
Leron seems to be the real deal though... this team just can’t get it to market.
This stock is heavily manipulated, but longs also know that’s. So it’s easy to sell the news and then buy back more at a lower price. So.... yes... Longs are selling to reconsolidate. Shorts are preaching negative spin ....
It’s the same old otc game...
Lalezari said it best... the drug did far better than they expected. I.e. they underestimated it. If they had chosen different (more serious) primary endpoints they would have met them.
The drug works... trial data will have to be examined below the primary. But the headline will be that they didn’t meet the primary.
Again, great drug... average showing due to trial structure.
Probably chose the wrong primary end points. Cydy took some criticism on their choices for M2M. Hgen modified their S2C since the soc has improved.
More experienced drug developers would have done better on endpoint selection. It’s not the drugs fault.
Uplist and Covid cure fomo will be extreme. But a drug isn’t worth a damn without FDA approval. That’s what the market is trading right now.
Seems like the drug working is priced in, the Big news is not
Good, I’m sure most would agree with that, there’s no data on it.
Fed gov and their lapdog media need to start learning about leronlimab quickly.